FDA Clearance Tracker · K261142
Ponto 5 Mini; Ponto 5 Superpower
Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 26, 2026
Substantially Equivalent
Time to decision
141 days
Received Apr 7, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K261142
- Device name
- Ponto 5 Mini; Ponto 5 Superpower
- Applicant
- Oticon Medical AB
- Applicant location
- Askim, SE
- Received
- Apr 7, 2026
- Decided
- Aug 26, 2026
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 874.3302
- Specialty
- Otolaryngology (ENT)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MAH. The earliest in FDA's data is K984162, decided Jun 28, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K261142
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Oticon Medical AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K240614 · Decided Jul 10, 2024 · 127 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
- Ponto 5 SuperPower510(k)
K213733 · Decided Dec 16, 2021 · 20 days after receipt
Device type: Hearing Aid, Bone Conduction (LXB) · Otolaryngology (ENT)
- Ponto 5 Mini510(k)
K211640 · Decided Aug 10, 2021 · 75 days after receipt
Device type: Hearing Aid, Bone Conduction (LXB) · Otolaryngology (ENT)
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.